Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2221, doi. 10.1042/CS20190873
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2019 AND VI 133 AND IP 21
Results: 8
1
2
A tangled tale of microRNA and cardiac fibrosis.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2217, doi. 10.1042/CS20190866
- By:
- Publication type:
- Article
3
Depletion of CD11c<sup>+</sup> dendritic cells in apolipoprotein E-deficient mice limits angiotensin II-induced abdominal aortic aneurysm formation and growth.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2203, doi. 10.1042/CS20190924
- By:
- Publication type:
- Article
4
Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2189, doi. 10.1042/CS20190679
- By:
- Publication type:
- Article
5
Particulate matter exposure aggravates osteoarthritis severity.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2171, doi. 10.1042/CS20190458
- By:
- Publication type:
- Article
6
Inhibition of human lung adenocarcinoma growth and metastasis by JC polyomavirus-like particles packaged with an SP-B promoter-driven CD59-specific shRNA.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2159, doi. 10.1042/CS20190395
- By:
- Publication type:
- Article
7
Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2143, doi. 10.1042/CS20190294
- By:
- Publication type:
- Article
8
Specialized pro-resolving mediators in diabetes: novel therapeutic strategies.
- Published in:
- Clinical Science, 2019, v. 133, n. 21, p. 2121, doi. 10.1042/CS20190067
- By:
- Publication type:
- Article